RhVEGF165 delivered in a porous β-tricalcium phosphate scaffold accelerates bridging of critical-sized defects in rabbit radii

Pei Yang, Chunsheng Wang, Zhibin Shi, Xin Huang, Xiaoqian Dang, Xudong Li, Shien-Fong Lin, Kunzheng Wang

Research output: Contribution to journalArticle

12 Citations (Scopus)

Abstract

Segmental bone defects are a common obstacle in major orthopedic procedures, and the treatment of these defects remains a challenging clinical problem. Bone tissue engineering has been attracting much attention in recent years. We evaluated the ability of the specific combination of 3 μg rhVEGF165 with a novel porous β-tricalcium phosphate (b-TCP) scaffold coated with fibrin sealant (FS) to facilitate bone regeneration. Unilateral 15-mm long criticalsized defects were prepared in the radial diaphysis of rabbits and treated with rhVEGF165/FS/scaffold or FS/scaffold. Healing of the defects was assessed at 4, 8, and 12 weeks, radiologically, histologically, and biomechanically. The results of the study demonstrated that the critical-sized defects in the midshaft of the rabbit radius, treated with rhVEGF165 incorporated in porous β-TCP scaffold by FS, can be completely bridged by cortical bone in 12 weeks. The bone marrow space was also reformed histologically and radiologically at 12 weeks postsurgery in the rhVEGF165-treated group. Furthermore, biomechanical examination demonstrated that the segmental bone defects were not only radiologically and histologically repaired but were also mechanically repaired. Interestingly, none of the defects was completely repaired at 12 weeks following treatment with FS/ scaffold without rhVEGF165. A solution-driven process is likely the predominant mechanism of accelerating biodegradation of the β-TCP scaffold in the presence of rhVEGF 165; furthermore, cell-mediated phagocytosis also contributes to biodegradation of the biomaterials.

Original languageEnglish
Pages (from-to)626-640
Number of pages15
JournalJournal of Biomedical Materials Research - Part A
Volume92
Issue number2
DOIs
StatePublished - Feb 2010

Fingerprint

Scaffolds
Fibrin Tissue Adhesive
Sealants
Phosphates
Bone
Defects
Biodegradation
Orthopedics
Biocompatible Materials
tricalcium phosphate
Tissue engineering
Biomaterials

Keywords

  • Adsorption
  • Biomaterial
  • Osteogenesis
  • Tissue engineering
  • Vascular endothelial growth factor

ASJC Scopus subject areas

  • Biomedical Engineering
  • Biomaterials
  • Ceramics and Composites
  • Metals and Alloys

Cite this

RhVEGF165 delivered in a porous β-tricalcium phosphate scaffold accelerates bridging of critical-sized defects in rabbit radii. / Yang, Pei; Wang, Chunsheng; Shi, Zhibin; Huang, Xin; Dang, Xiaoqian; Li, Xudong; Lin, Shien-Fong; Wang, Kunzheng.

In: Journal of Biomedical Materials Research - Part A, Vol. 92, No. 2, 02.2010, p. 626-640.

Research output: Contribution to journalArticle

Yang, Pei ; Wang, Chunsheng ; Shi, Zhibin ; Huang, Xin ; Dang, Xiaoqian ; Li, Xudong ; Lin, Shien-Fong ; Wang, Kunzheng. / RhVEGF165 delivered in a porous β-tricalcium phosphate scaffold accelerates bridging of critical-sized defects in rabbit radii. In: Journal of Biomedical Materials Research - Part A. 2010 ; Vol. 92, No. 2. pp. 626-640.
@article{0344bd6257bb4dbfa433bfa2bb0b18ca,
title = "RhVEGF165 delivered in a porous β-tricalcium phosphate scaffold accelerates bridging of critical-sized defects in rabbit radii",
abstract = "Segmental bone defects are a common obstacle in major orthopedic procedures, and the treatment of these defects remains a challenging clinical problem. Bone tissue engineering has been attracting much attention in recent years. We evaluated the ability of the specific combination of 3 μg rhVEGF165 with a novel porous β-tricalcium phosphate (b-TCP) scaffold coated with fibrin sealant (FS) to facilitate bone regeneration. Unilateral 15-mm long criticalsized defects were prepared in the radial diaphysis of rabbits and treated with rhVEGF165/FS/scaffold or FS/scaffold. Healing of the defects was assessed at 4, 8, and 12 weeks, radiologically, histologically, and biomechanically. The results of the study demonstrated that the critical-sized defects in the midshaft of the rabbit radius, treated with rhVEGF165 incorporated in porous β-TCP scaffold by FS, can be completely bridged by cortical bone in 12 weeks. The bone marrow space was also reformed histologically and radiologically at 12 weeks postsurgery in the rhVEGF165-treated group. Furthermore, biomechanical examination demonstrated that the segmental bone defects were not only radiologically and histologically repaired but were also mechanically repaired. Interestingly, none of the defects was completely repaired at 12 weeks following treatment with FS/ scaffold without rhVEGF165. A solution-driven process is likely the predominant mechanism of accelerating biodegradation of the β-TCP scaffold in the presence of rhVEGF 165; furthermore, cell-mediated phagocytosis also contributes to biodegradation of the biomaterials.",
keywords = "Adsorption, Biomaterial, Osteogenesis, Tissue engineering, Vascular endothelial growth factor",
author = "Pei Yang and Chunsheng Wang and Zhibin Shi and Xin Huang and Xiaoqian Dang and Xudong Li and Shien-Fong Lin and Kunzheng Wang",
year = "2010",
month = "2",
doi = "10.1002/jbm.a.32403",
language = "English",
volume = "92",
pages = "626--640",
journal = "Journal of Biomedical Materials Research - Part A",
issn = "1549-3296",
publisher = "John Wiley and Sons Inc.",
number = "2",

}

TY - JOUR

T1 - RhVEGF165 delivered in a porous β-tricalcium phosphate scaffold accelerates bridging of critical-sized defects in rabbit radii

AU - Yang, Pei

AU - Wang, Chunsheng

AU - Shi, Zhibin

AU - Huang, Xin

AU - Dang, Xiaoqian

AU - Li, Xudong

AU - Lin, Shien-Fong

AU - Wang, Kunzheng

PY - 2010/2

Y1 - 2010/2

N2 - Segmental bone defects are a common obstacle in major orthopedic procedures, and the treatment of these defects remains a challenging clinical problem. Bone tissue engineering has been attracting much attention in recent years. We evaluated the ability of the specific combination of 3 μg rhVEGF165 with a novel porous β-tricalcium phosphate (b-TCP) scaffold coated with fibrin sealant (FS) to facilitate bone regeneration. Unilateral 15-mm long criticalsized defects were prepared in the radial diaphysis of rabbits and treated with rhVEGF165/FS/scaffold or FS/scaffold. Healing of the defects was assessed at 4, 8, and 12 weeks, radiologically, histologically, and biomechanically. The results of the study demonstrated that the critical-sized defects in the midshaft of the rabbit radius, treated with rhVEGF165 incorporated in porous β-TCP scaffold by FS, can be completely bridged by cortical bone in 12 weeks. The bone marrow space was also reformed histologically and radiologically at 12 weeks postsurgery in the rhVEGF165-treated group. Furthermore, biomechanical examination demonstrated that the segmental bone defects were not only radiologically and histologically repaired but were also mechanically repaired. Interestingly, none of the defects was completely repaired at 12 weeks following treatment with FS/ scaffold without rhVEGF165. A solution-driven process is likely the predominant mechanism of accelerating biodegradation of the β-TCP scaffold in the presence of rhVEGF 165; furthermore, cell-mediated phagocytosis also contributes to biodegradation of the biomaterials.

AB - Segmental bone defects are a common obstacle in major orthopedic procedures, and the treatment of these defects remains a challenging clinical problem. Bone tissue engineering has been attracting much attention in recent years. We evaluated the ability of the specific combination of 3 μg rhVEGF165 with a novel porous β-tricalcium phosphate (b-TCP) scaffold coated with fibrin sealant (FS) to facilitate bone regeneration. Unilateral 15-mm long criticalsized defects were prepared in the radial diaphysis of rabbits and treated with rhVEGF165/FS/scaffold or FS/scaffold. Healing of the defects was assessed at 4, 8, and 12 weeks, radiologically, histologically, and biomechanically. The results of the study demonstrated that the critical-sized defects in the midshaft of the rabbit radius, treated with rhVEGF165 incorporated in porous β-TCP scaffold by FS, can be completely bridged by cortical bone in 12 weeks. The bone marrow space was also reformed histologically and radiologically at 12 weeks postsurgery in the rhVEGF165-treated group. Furthermore, biomechanical examination demonstrated that the segmental bone defects were not only radiologically and histologically repaired but were also mechanically repaired. Interestingly, none of the defects was completely repaired at 12 weeks following treatment with FS/ scaffold without rhVEGF165. A solution-driven process is likely the predominant mechanism of accelerating biodegradation of the β-TCP scaffold in the presence of rhVEGF 165; furthermore, cell-mediated phagocytosis also contributes to biodegradation of the biomaterials.

KW - Adsorption

KW - Biomaterial

KW - Osteogenesis

KW - Tissue engineering

KW - Vascular endothelial growth factor

UR - http://www.scopus.com/inward/record.url?scp=75149134227&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=75149134227&partnerID=8YFLogxK

U2 - 10.1002/jbm.a.32403

DO - 10.1002/jbm.a.32403

M3 - Article

C2 - 19235222

AN - SCOPUS:75149134227

VL - 92

SP - 626

EP - 640

JO - Journal of Biomedical Materials Research - Part A

JF - Journal of Biomedical Materials Research - Part A

SN - 1549-3296

IS - 2

ER -